Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Posted on by ScienceFather

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Assoc. Prof. Dr Lucia Ciranna, Università di Catania, Italy

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her groundbreaking research on the serotonin brain system, Fragile X Syndrome, and neurodevelopmental disorders. With a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg (1995) and a Pharmacy degree from the University of Catania (1989), she has significantly advanced understanding of neurological diseases. As an Associate Professor of Physiology at the University of Catania since 2006, she has led innovative studies on neurodevelopment and therapeutic interventions. Her extensive research contributions, spanning over three decades, have earned her prestigious qualifications in France and Italy. Dr. Ciranna’s work has been instrumental in exploring the therapeutic potential of serotonin modulation, glial interactions, and receptor mechanisms in neurological disorders. Her prolific publication record and dedication to advancing neuroscience make her a deserving recipient of the Women Researcher Award. 🧠📚🏅

Publication Profile

Scopus

Education 

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist with a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg, France (1995) 🧠, where she focused on serotonin neurotransmission and neurodevelopment. She earned her Pharmacy degree from the University of Catania (1989) 💊, specializing in neuropharmacology and brain physiology. Her postdoctoral research at the University of Catania (1995-1998) 🔬 explored serotonin’s role in synaptic plasticity and cognition. Further advancing her expertise, she trained in molecular neuroscience and pharmacology (1998-2000) 🎓. Dedicated to lifelong learning, she actively engages in international neuroscience workshops and research collaborations 📖.

Experience

Assoc. Prof. Dr. Lucia Ciranna is a distinguished physiologist at the University of Catania (2006-Present) 🏫, leading groundbreaking research on serotonin’s role in neurological disorders and innovative therapeutic strategies. Previously, she was a researcher at the same institution (1994-2006) 🔬, investigating neurophysiology in cognitive impairments and receptor signaling. She earned her Ph.D. from Louis Pasteur University of Strasbourg (1990-1994) 🎓, focusing on neurodevelopmental mechanisms and serotonin modulation in brain function. Earlier, she contributed to neuropharmacology research at the University of Catania (1989-1990) 🧬. As a scientific collaborator with international neuroscience labs 🌍, she continues exploring cutting-edge advancements in the field.

Awards and Honors

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her contributions to neurophysiology 🧠. She achieved the Qualification to the function of Professeur des Université in France (2012) 🇫🇷 and later became a Professore Ordinario (Full Professor of Physiology) in 2018 🎓. Her research has been supported by prestigious international neuroscience grants 💰, driving innovation in the field. A sought-after speaker, she has delivered distinguished lectures at major neurophysiology conferences worldwide 🎤. Dr. Ciranna’s groundbreaking work on Fragile X Syndrome has earned her accolades for excellence in neurodevelopmental research 🏅.

Presentation

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist specializing in serotonin receptor modulation and its implications for neurodevelopmental disorders 🧠🔬. She has delivered numerous invited seminars and conference presentations worldwide, focusing on the role of 5-HT7 serotonin receptors in synaptic plasticity, cognition, and behavior. Her research explores therapeutic strategies for Fragile X Syndrome and Autism Spectrum Disorders, with key contributions to understanding serotonin-mediated neuromodulation 🎓🧪. Dr. Ciranna has also engaged in public science communication, appearing on RAI Telethon broadcasts 📺. Her work continues to shape novel approaches for treating cognitive disorders through serotonin receptor activation. 🌍📚

Research Focus

Assoc. Prof. Dr. Lucia Ciranna is dedicated to unraveling the complexities of the serotonin brain system 🧠, exploring its role in neurological disorders and potential therapeutic interventions. Her research focuses on Fragile X Syndrome 🧬, aiming to develop targeted treatments for cognitive deficits. She investigates neurodevelopmental disorders 💡, shedding light on autism, intellectual disabilities, and brain dysfunctions. Her work also delves into glial-neuronal interactions 🤝, examining their impact on neurodevelopment and inflammation. Passionate about therapeutic innovations in neuroscience 🏥, she seeks novel drug targets and treatment strategies to improve neurological health and patient outcomes.

Publication Top Notes 

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells

Editorial: Role of glia in neurodevelopmental disorders

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease

Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia

Sangil Park | Medical Hypotheses | Best Researcher Award

Posted on by ScienceFather

Sangil Park | Medical Hypotheses | Best Researcher Award

Prof Sangil Park, Department of Neurology, Uijeongbu Eulji Medical Center, South Korea

Prof. Sangil Park is a dedicated neurologist and clinical researcher with expertise in stroke, neurocritical care, and neuro-intervention. 🧠💉 He serves as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center and has completed fellowships in radiology, neurology, and critical care. 🌟📚 Holding a Ph.D. from Kyung Hee University, Dr. Park is certified in neurology, acute stroke care, and critical care medicine. 🎓🏅 His research includes innovative treatments for vascular diseases and digital health applications. 🩺📊 An active member of multiple neurological societies, he has published extensively and presented at international conferences. 🌍📝 Dr. Park’s work reflects a passion for advancing neurological care. ✨

Publication Profile

Orcid

Education 

Prof. Sangil Park boasts an impressive educational journey and certifications in medicine and engineering. He earned his Ph.D. in Medicine from Kyung Hee University (2023) 🧑‍🎓, where he also completed his M.D. (2014) 🩺. Prior to this, he obtained a B.D. in Electrical Engineering and Computer Science from Hanyang University (2009) 💻. Prof. Park holds the Korean Board of Neurology (2022) 🧠, the Certification of TPI from The Korean Orthopedic Pain Society (2022) 🏥, and the Subspecialty Board of Critical Care Medicine (2024) 🫀. Additionally, he is a certified Acute Stroke Neurologist (2024) ⚡, blending expertise in neurology and technology.

Career Background 

Prof. Sangil Park is a dedicated neurologist with extensive clinical experience and academic achievements. Since March 2024, he has been serving as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center 🏥. He previously held fellowships in Radiology at Asan Medical Center (2023-2024) and in Neurology and Critical Care Medicine at Kyung Hee University Medical Center (2022-2023) 🔬🧠. Prof. Park completed his Neurology residency at Kyung Hee University Hospital at Gangdong (2018-2022) and internship at Kyung Hee University Medical Center (2017-2018) 👨‍⚕️. His military service included working as a public health doctor in Changnyeong-gun (2014-2017) 🚑🇰🇷.

Experience

Prof. Sangil Park’s groundbreaking work focuses on neurological and cerebrovascular health through advanced clinical research. 🌟🧠 He led a post-marketing safety study on Emgality (Galcanezumab) for migraine prophylaxis in adults in Korea (SIT, PMS2020-014-005) 💊, and explored neuroprotection with neu2000 in acute ischemic stroke patients through a phase-III randomized trial (2021-10-090). 🔬 In another study, he evaluated atrial fibrillation’s prevalence and impact in elderly patients with cryptogenic stroke and patent foramen ovale (2021-04-034). 💓 His contributions extend to assessing Choline Alfoscerate’s safety and efficacy in mild cognitive impairment with cerebrovascular disease in a phase-IV trial (2021-07-094). 🧪📈

Presentation 

Prof. Sangil Park has contributed extensively to stroke and neurovascular research. Key presentations include delayed post-hypoxic leukoencephalopathy after ischemic stroke at the 15th ESMINT Congress (2023) 🧠, and styloidogenic jugular venous compression syndrome at the Asia Pacific Stroke Conference (2022) 🩺. His studies on carotid artery restenosis after stenting at the 14th World Stroke Congress (2022) and predictors of in-stent restenosis at the KSIN Summer Intensive Course (2024) provide valuable insights 📊. Prof. Park has also explored COVID-19 vaccination’s link to ischemic stroke 🦠 and innovative treatments for cavernous sinus dural AVFs (2023) 🩸, advancing neurovascular care worldwide. 🌍

Professional Recognition 

Prof. Sangil Park is a dedicated neurologist with memberships in multiple prestigious societies, reflecting his commitment to advancing the field. 🌍📚 His consistent focus on cutting-edge research has significantly contributed to the understanding and treatment of neurological conditions. 🧠🔬 Specializing in stroke and neurocritical care, Prof. Park has made impactful strides in improving patient outcomes through collaborative research efforts. 🤝💡 His work bridges innovation and clinical application, ensuring better care for patients worldwide. 🏥🌟 A true leader in neurology, he continues to inspire progress in the field, shaping the future of neuroscience and neurocritical care. 🚀✨

Research Focus

Prof. Sangil Park’s research primarily focuses on neurovascular diseases, endovascular treatments, and innovative diagnostic approaches. His studies include targeted embolization for cavernous sinus dural arteriovenous fistulas 💉🧠, advanced imaging markers like the HARM sign for transient ischemic attacks 🩻🚨, and real-world applications of digital health technologies for chronic conditions like hypertension and diabetes 📱💊. His work extends to rare conditions, such as medullary hemangioblastomas and cerebral vasculitis 🩸🧬, reflecting a broad interest in improving patient outcomes through multidisciplinary approaches. His contributions to neurosonology and embolization emphasize precision medicine in neurology and radiology. 🌟📚

Publication Top Notes

Endovascular Treatment With Targeted Embolization of Cavernous Sinus Dural Arteriovenous Fistulas: A Single-Center Study

Hyperintense Acute Reperfusion Marker Sign in Patients with Diffusion Weighted Image-negative Transient Ischemic Attack HARM Sign in DWI-negative TIA

Ruptured Medullary Hemangioblastoma Mimicking a Craniocervical Junction Dural Arteriovenous Fistula with a Pseudoaneurysm

Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study

Real-World Evidence of a Hospital-Linked Digital Health App for the Control of Hypertension and Diabetes Mellitus in South Korea: Nationwide Multicenter Study (Preprint)

Klebsiella pneumoniae Cerebritis Masquerading as Hyperacute Middle Cerebral Artery Syndrome

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence 🎓🏥. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations 🌟📚. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research 🔬💉. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology 🌍💪.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. 🌍🍽️📚💡🌱

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. 🍽️🏥💪📚

Publication top Notes

Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials

Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma

ESPEN practical guideline: Home parenteral nutrition

How to deal with micronutrient product shortage – Editorial

Cost of HPN in incurable cancer patients: Author’s response re. “SINPE Position Paper on the use of home parenteral nutrition in cancer patients”

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer

Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives

TEMPORARY REMOVAL: SINPE Position Paper on the use of home parenteral nutrition in cancer patients

CEZARY WASILCZYK | Medical Hypotheses | Medical Hypothesis Award

Posted on by ScienceFather

CEZARY WASILCZYK | Medical Hypotheses | Medical Hypothesis Award

Mr CEZARY Wasilczyk, Wasilczyk Medical Clinic Indywidualna Praktyka Lekarska Cezary Wasilczyk, Poland

Based on the impressive qualifications and extensive contributions of Dr. Ceary Wasilczyk, he is indeed a suitable candidate for the Best Researcher Award. Here’s a detailed breakdown of his qualifications, experience, and contributions to support this assessment:

Publication profile

Scopus

Education

Dr. Cezyary Wasilczyk earned his Doctor’s degree from the Academy of Medicine in Białystok, Poland, from 1996 to 2002. His foundational education includes secondary school and musical training, demonstrating a diverse background.

Professional Experience

  • Chief of Orthopedics Department (2015 – 2024) at Wasilczyk Medical Clinic, where he specializes in arthroscopy and ultrasound examinations.
  • Notable scientific contributions in Nano Surgery and Bioengineering treatments, particularly under ultrasound guidance.
  • Ph.D. (2015) from the Center of Postgraduate Medical Education in Warsaw, focusing on ultrasonography for meniscal tears.
  • Founder of the Ultrasonography School “Sonomasters,” with over 100 lectures on ultrasound for medical professionals.
  • Active member and chairman at international congresses such as ISMUS, enhancing knowledge in musculoskeletal ultrasound.

Research Contributions

  • PhD Research: His doctoral thesis on the ultrasonographic evaluation of meniscal tears reflects a significant contribution to orthopedic imaging and surgical techniques.
  • Published Works: Ceary has authored multiple publications, including two volumes of an ultrasound atlas and studies on ultrasound diagnostics and innovative treatments. These contributions advance the understanding of orthopedic injuries and treatments, underscoring his research impact.
  • Clinical Trials Participation: His involvement in international clinical trials further solidifies his role as an active researcher in orthopedic medicine.

Scientific Impact

  • Focus on Advancements: His research in nano-surgical techniques and bioengineering for treating ligament injuries highlights his role at the forefron

Professional Affiliations and Contributions

  • Founder of Ultrasonography School: His role in educating over 100 ultrasound courses indicates a dedication to advancing medical education.
  • Membership in ISMUS: Participation in international congresses and research trials demonstrates his active engagement in the global medical community.

Conclusion

Dr. CeZary Wasilczyk’s multifaceted contributions to orthopedics, dedication to medical education, and innovative research make him an outstanding candidate for the Best Researcher Award. His commitment to advancing medical practice through ultrasound technology and surgical techniques is exemplary, reflecting a significant impact on both his patients and the medical community at large.

Publication top notes

Nanosurgical and Bioengineering Treatment of Human Anterior Cruciate Ligament Tears with Ultrasound-Guided Injection of Modified Platelet-Rich Plasma Using Human Cell Memory Based on Clinical, Ultrasound, MRI, and Nanoscope Analyses: A Double-Blind Randomized Trial

The Value of Ultrasound Diagnostic Imaging of Anterior Crucial Ligament Tears Verified Using Experimental and Arthroscopic Investigations

The Value of Ultrasound Diagnostic Imaging of Meniscal Knee Injuries Verified by Experimental and Arthroscopic Investigations

 

 

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.

Publication top notes

Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus

Prevalence of avian respiratory viruses in broiler flocks in Egypt

Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens

Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United States

Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns

Molecular characterization of Newcastle disease virus (genotype VII) from broiler chickens in Egypt

Co-infections, genetic, and antigenic relatedness of avian influenza H5N8 and H5N1 viruses in domestic and wild birds in Egypt

Protective efficacy of different live attenuated infectious bronchitis virus vaccination regimes against challenge with IBV variant-2 circulating in the Middle East

The emergence, evolution and spread of infectious bronchitis virus genotype GI-23

Hsuan-Wei Liu | Medical Hypotheses | Best Researcher Award

Posted on by ScienceFather

Hsuan-Wei Liu | Medical Hypotheses | Best Researcher Award

Ms Hsuan-Wei Liu, China Medical University, Taiwan

Ms. Hsuan-Wei Liu is a dedicated researcher specializing in orthopedics and geriatrics, focusing on the effects of resistance training with elastic bands on bone mineral density, body composition, and osteosarcopenic obesity in elderly women. Her meta-analysis highlights significant improvements in skeletal health and obesity-related metrics through targeted exercise interventions. Ms. Liu’s work underscores her commitment to advancing knowledge in geriatric orthopedics, aiming to enhance quality of life for aging populations. 📊

Publication profile

orcid

scopus

Research focus

Hsiu-Wei Liu’s research primarily focuses on the impact of resistance training and physical exercise on musculoskeletal health, particularly in elderly populations. Their work includes systematic reviews and meta-analyses on how resistance training, including the use of elastic bands, affects bone mineral density, body composition, and conditions like osteosarcopenic obesity. This indicates a strong emphasis on rehabilitation and preventive care in orthopedics and geriatrics. Liu’s research is crucial for improving the quality of life and functional independence in aging individuals, aligning with the fields of sports science, orthopedics, and gerontology. 🏋️‍♀️🦴👵🔬

Publication top notes

Resistance training in patients with total knee arthroplasty: A systematic review and meta-analysis

Effects of resistance training with elastic bands on bone mineral density, body composition, and osteosarcopenic obesity in elderly women: A meta-analysis

Medical Hypothesis Award

Posted on by ScienceFather

Medical Hypothesis Award

Introduction:

Welcome to the Medical Hypothesis Award, recognizing visionary ideas and innovative thinking in the realm of medical research. This prestigious award celebrates individuals who dare to challenge conventional wisdom and propose groundbreaking hypotheses that have the potential to revolutionize healthcare.

Award Overview:

The Medical Hypothesis Award acknowledges individuals who have demonstrated exceptional creativity and foresight in proposing novel hypotheses that address pressing medical challenges and offer promising avenues for further investigation and discovery.

Eligibility:

  • Open to medical researchers, clinicians, and scientists of all ages
  • No age limits apply
  • Qualification: Demonstration of innovative thinking and originality in hypothesis formulation
  • Publications: Evidence of hypothesis presentation in peer-reviewed journals or academic conferences
  • Recurrements: Continued commitment to pushing the boundaries of medical knowledge through hypothesis-driven research

Evaluation Criteria:

Candidates will be evaluated based on the following criteria:

  1. Originality and novelty of the proposed hypothesis
  2. Potential impact on advancing medical knowledge or clinical practice
  3. Clarity and coherence in hypothesis presentation
  4. Feasibility and potential for future investigation

Submission Guidelines:

  • Submit a detailed biography highlighting relevant experience and expertise
  • Include an abstract summarizing the proposed hypothesis and its significance
  • Provide supporting files such as research papers, conference presentations, or supplementary materials

Recognition:

Recipients of the Medical Hypothesis Award will receive:

  • A prestigious award certificate
  • Recognition at a prominent medical conference or symposium
  • Opportunities for collaboration and networking with leading experts in the field

Community Impact:

Winners of the award are expected to inspire and catalyze further research efforts within the medical community, fostering a culture of innovation and collaboration aimed at addressing pressing healthcare challenges.

Biography:

A comprehensive biography outlining the candidate's professional background, research interests, and contributions to medical science is required.

Abstract and Supporting Files:

Candidates must submit an abstract outlining the proposed hypothesis along with supporting files such as research papers, conference presentations, or supplementary materials to substantiate their ideas.